Researchers sought to estimate the incidence for shingles in adults with MS and in a general immunocompetent population.

In an unblinded observational study, researchers assessed psychological, biological, and MRI changes associated with mindfulness-based stress reduction in MS.

Researchers assessed the feasibility of a 12-week high-intensity forced exercise or voluntary aerobic exercise intervention, and examined the impact on health-related quality of life and fatigue in patients with MS.

Researchers sought to examine the influence of S1P receptor modulators’ clinical management considerations on the preferences of patients with RRMS in the US.

Researchers sought to review pregnancy outcomes during ozanimod use in the clinical development program in all studies in which patients with RMS, UC, or CD or volunteer control individuals received ozanimod.

Researchers sought to fill in a gap regarding the psychosocial functioning of Hispanic and Black/African American individuals with multiple sclerosis in the US vs Latin America.

In an interim analysis, researchers reported on the open-label extension period on safety and tolerability of VidoCa in relapsing-remitting MS.

Researchers sought to report MRI, efficacy, and safety outcomes at week 96 of the phase 2b trial long-term safety extension in patients with relapsing MS and highly active disease.

Using optical coherence tomography angiography, researchers compared retinal microvasculature in patients with MS vs healthy individuals.

Researchers sought to examine the effects of fatigue on cognition in patients with MS via the MFIS and SDMT, before and during MEG study.

Researchers sought to compare real-world safety profiles of dimethyl fumarate and fingolimod via data from the FDA’s Adverse Event Reporting System database.

Researchers sought to compare the effects of a diet and therapeutic lifestyle telehealth intervention vs standard of care on perceived quality of life and fatigue in patients newly diagnosed with CIS or RRMS.

In a secondary data analysis, researchers estimated health resource utilization (HRU), including infection-related HRU, relapses, and costs in patients with stable MS who switched from anti-CD20 to fumarate.

Researchers reported on the primary safety and efficacy data from patients with early RRMS, treated with ocrelizumab over 4 years in the open-label, single-arm, phase 3b ENSEMBLE study.

Researchers sought to investigate the humoral response of patients with RMS, treated with evobrutinib who received mRNA and non-mRNA COVID-19 vaccines during the open-label extension of a phase II clinical trial.

In a retrospective, cross-sectional study, researchers characterized MS presentation in Latinx patients compared with non-White Latinx patients.

Researchers sought to assess the overall impact of exercise interventions on HRQOL in patients with MS, the overall strength of evidence of exercise interventions on the physical and mental domains of HRQOL, and establish moderators of exercise intervention effects on HRQOL.

In a large population-based study, researchers determined the associations between MS during pregnancy and the risk for perinatal adverse outcomes.

Researchers sought to evaluate whether fertility, pregnancy, delivery, and breastfeeding have been improving among women with MS, compared with the general population, and in relation to treatment features.

Researchers sought to characterize immune responses to SARS-CoV-2 vaccinations among patients with MS who received anti-CD20 therapy and who were vaccinated 2 to 4 times.

Researchers sought to assess the effect of assisted reproductive technologies on relapse risk among women with multiple sclerosis receiving treatment with disease-modifying immunomodulatory treatment.

Researchers sought to assess the long-term effect of ofatumumab (OMB) on sNfL levels and NEDA-3 in patients with relapsing MS who receive continuous OMB and those who converted from teriflunomide in ASCLEPIOS I/II and ALITHIOS.

Researchers sought to assess the characteristics of patients who discontinued first-line DMT, and the occurrence of clinical and radiologic inflammatory disease activity following DMT discontinuation.

Researchers sought to assess the impact of smoking habits, exposure to passive smoking, and snuff use on disease progression, cognitive performance, and quality of life in patients with MS.

In a systematic review, researchers examined the effects of music therapy intervention on patients with multiple sclerosis with gait disorders.

In an observational retrospective study, researchers evaluated annualized relapse rate 12 months pre-fertility treatment and 3 months post-fertility treatment and identified factors related with increased relapse risk.

In a retrospective cohort study, researchers evaluated the differences in fracture risk between patients with NMOSD and MS compared to that of healthy individuals.

For women with multiple sclerosis (MS), there is no increased relapse rate after fertility treatment (FT).

Researchers assessed the relationship between higher ocrelizumab exposure and confirmed disability progression.

In a randomized controlled trial, researchers assessed the effects of TR and V-TOXT on upper limb, trunk function, and functional activity kinematics in patients with MS.